Reverse Merger - Other Information (Details) - USD ($) $ in Millions	Dec. 31, 2023	Dec. 18, 2023	Dec. 31, 2022
Business Acquisition [Line Items]
Common stock, shares, outstanding (in shares)	12,823,665		0
Neoleukin
Business Acquisition [Line Items]
Common stock, shares, outstanding (in shares)		2,351,030
Short term investments		$ 53.9
Asset acquisition, recognized identifiable assets acquired and liabilities assumed, cash and equivalents		22.2
Other assets		0.8
Lease obligation		10.9
Accrued payroll		3.8
Other accrued costs and accounts payable		$ 6.3
Neoleukin | Pre-Funded Warrant
Business Acquisition [Line Items]
Class of warrant or right, outstanding (in shares)		425,987